Haploinsufficiency of mechanistic target of rapamycin ameliorates bag3 cardiomyopathy in adult zebrafish
Author
Ding, YongheDvornikov, Alexey V
Ma, Xiao
Zhang, Hong
Wang, Yong
Lowerison, Matthew
Packard, Rene R
Wang, Lei
Chen, Jun
Zhang, Yuji
Hsiai, Tzung
Lin, Xueying
Xu, Xiaolei
Affiliation
Univ Arizona, Dept Cellular & Mol MedIssue Date
2019-10-01
Metadata
Show full item recordPublisher
COMPANY BIOLOGISTS LTDCitation
Ding, Y., Dvornikov, A. V., Ma, X., Zhang, H., Wang, Y., Lowerison, M., ... & Hsiai, T. (2019). Haploinsufficiency of mechanistic target of rapamycin ameliorates bag3 cardiomyopathy in adult zebrafish. Disease models & mechanisms, 12(10), dmm040154.Journal
DISEASE MODELS & MECHANISMSRights
Copyright © 2019. Published by The Company of Biologists Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
The adult zebrafish is an emerging vertebrate model for studying human cardiomyopathies; however, whether the simple zebrafish heart can model different subtypes of cardiomyopathies, such as dilated cardiomyopathy (DCM), remains elusive. Here, we generated and characterized an inherited DCM model in adult zebrafish and used this model to search for therapeutic strategies. We employed transcription activator-like effector nuclease (TALEN) genome editing technology to generate frame-shift mutants for the zebrafish ortholog of human BCL2-associated athanogene 3 (BAG3), an established DCM-causative gene. As in mammals, the zebrafish bag3 homozygous mutant (bag3e2/e2 ) exhibited aberrant proteostasis, as indicated by impaired autophagy flux and elevated ubiquitinated protein aggregation. Through comprehensive phenotyping analysis of the mutant, we identified phenotypic traits that resembled DCM phenotypes in mammals, including cardiac chamber enlargement, reduced ejection fraction characterized by increased end-systolic volume/body weight (ESV/BW), and reduced contractile myofibril activation kinetics. Nonbiased transcriptome analysis identified the hyperactivation of the mechanistic target of rapamycin (mTOR) signaling in bag3e2/e2 mutant hearts. Further genetic studies showed that mtorxu015/+ , an mTOR haploinsufficiency mutant, repaired abnormal proteostasis, improved cardiac function and rescued the survival of the bag3e2/e2 mutant. This study established the bag3e2/e2 mutant as a DCM model in adult zebrafish and suggested mtor as a candidate therapeutic target gene for BAG3 cardiomyopathy.ISSN
1754-8403PubMed ID
31492659Version
Final published versionSponsors
American Heart Association [14SDG18160021]; Mayo Clinic; United States Department of Health & Human Services National Institutes of Health (NIH) - USA [HL81753, HL107304, HL111437, GM63904]; Mayo Foundation for Medical Education and Researchae974a485f413a2113503eed53cd6c53
10.1242/dmm.040154
Scopus Count
Collections
Related articles
- Genetic compensation prevents myopathy and heart failure in an in vivo model of Bag3 deficiency.
- Authors: Diofano F, Weinmann K, Schneider I, Thiessen KD, Rottbauer W, Just S
- Issue date: 2020 Nov
- Whole exome sequencing identified 1 base pair novel deletion in BCL2-associated athanogene 3 (BAG3) gene associated with severe dilated cardiomyopathy (DCM) requiring heart transplant in multiple family members.
- Authors: Rafiq MA, Chaudhry A, Care M, Spears DA, Morel CF, Hamilton RM
- Issue date: 2017 Mar
- Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish.
- Authors: Ding Y, Sun X, Huang W, Hoage T, Redfield M, Kushwaha S, Sivasubbu S, Lin X, Ekker S, Xu X
- Issue date: 2011 Sep 2
- P209L mutation in Bag3 does not cause cardiomyopathy in mice.
- Authors: Fang X, Bogomolovas J, Zhou PS, Mu Y, Ma X, Chen Z, Zhang L, Zhu M, Veevers J, Ouyang K, Chen J
- Issue date: 2019 Feb 1
- Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy.
- Authors: Dvornikov AV, Wang M, Yang J, Zhu P, Le T, Lin X, Cao H, Xu X
- Issue date: 2019 Aug